Avipoxvirus infection in a collection of captive stone curlews (Burhinus oedicnemus).

A natural outbreak of avipoxvirus occurred in recently purchased stone curlews (Burhinus oedicnemus) at a breeding farm and subsequently spread to other stone curlews residing at the farm. The initial outbreak was characterized by mild vesicular skin lesions on the legs, which then developed crusts and bled. The overall morbidity rate was 100%, but none of the birds died, and all recovered without complication. Four gallinaceous species, also kept on the farm, did not develop lesions. Avipoxvirus was identified from the skin lesions by virus isolation, electron microscopy, and monoclonal antibody testing, as well as by polymerase chain reaction testing. Eight months after this outbreak, 7 male stone curlews developed large, round, crusty lesions on their legs. Although poxvirus virions were identified in the lesions, results of virus isolation were negative. These lesions possibly were the result of a recrudescence of the original infection in male birds that were stressed because they were housed together during the breeding season. This is the first clinical description of an avipoxvirus infection in stone curlews.

[The prevalence of Yersinia-specific antibodies in cattle in Bavaria]. / Untersuchungen zur Prävalenz Yersinia-spezifischer Antikörper bei Rindern in Bayern.

Yersiniosis is considered to be an emerging infection in humans. It is believed that contaminated pork is the main source of infection for man but also beef and cow milk might cause infection in the consumer. Therefore, a survey was carried out to obtain actual data on the prevalence of anti-Yersinia antibodies within cattle. 600 serum samples were taken form 120 farms located in 43 districts of Bavaria, Germany. Antibodies were detected in 396 animals (65.7%) revealing a distribution of 52.3% of anti-YopD, 40.3% of anti-YopM, 24.0% of anti-YopH, 21.2% of anti-YopE and 3.0% of anti-V-antigen antibodies. 21 reactionpatterns out of 32 possible patterns were identified. Anti-YopD and YopM antibodies were sufficient to detect all Yersinia antibody positive sera. No regional differences in the distribution of antibodies were noted.

[Comparative studies with three different bovine blood sample BHV-1 ELISA tests: indirect ELISA and bG-blocking-ELISA]. / Vergleichende Untersuchung von Rinderblutproben mit drei verschiedenen BHV-1 ELISA-Tests: Indirekter ELISA und gB-Blocking-ELISAs.

A total of 2754 bovine blood samples were examined for BHV1 antibodies in three different BHV-1 ELISA tests. The tests used were the CHEKIT Trachitest 2nd. Gen. "Bestätigungstest" Serum, the CHEKIT-BHV-1-gB-ELISA (Bommeli-Diagnostics/Intervet), and the BHV-1-gB Antibody Test Kit (IDEXX). A first testing identified 111 (4.0%) of the samples as positive and 2501 (90.8%) samples negative in all three tests. Onehundredand-fortytwo (5.2%) of the samples showed a not negative result in at least one of the two gB-ELISAs. The testing was repeated for 139 of the 142 samples and still 89 (3.2%) samples were found with discrepant results. The remaining 50 samples showed a negative reaction in the three ELISA tests. After Western blot analysis antibodies against glycoprotein B (gB) of BHV-1 were only detected in 11 of the 89 samples with a not negative reaction in at least one of the gB-ELISAs. Three of the 50 ELISA-negative samples showed a positive reaction in the Western blot. The high number of positive results in the gB-ELISAs which were negative in the Western blot assay leads to the conclusion that gB-ELISAs may have a lower specificity as the indirect ELISA. Introducing the gB-ELISA as the standard test for BHV1 serology in Bavaria would result to an increase of the number of BHV-1 positive farms by 8% (gB IDEXX) or 20% (gB Bommeli) 20%.

[BHV-1 eradication program in Bavaria: a marker-independent strategy]. / BHV-1-Bekämpfung in Bayern: Eine markerunabhängige Strategie.

In Bavaria a BHV-1 eradication program was initiated in 1986 and was changed to a compulsory program in 1998. The eradication success increased progressively from < 50% in 1986 to 87% of the farms in 2002. BHV 1-free farms are controlled by bulk milk serology twice a year along with blood serology in animals that are negative but from herds where positive field virus infected animals are present. All serological tests are performed with an indirect ELISA test, all positive results are confirmed by a gB ELISA. Currently about 100.000 virus infected cattle are in Bavarian herds, approximately 80% of these animals are in heavily infected herds (> 10 infected animals). These herds comprise about 5% of all Bavarian herds. The eradication of the virus in these heavily infected herds is the most diifficult, whereas the prevention of new infections appears controllable. In this review current problems in BHV1 eradication are named and possible improvements are discussed.

Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating construct.

Handling of Vaccinia virus represents a risk for laboratory-acquired infections, especially in individuals without completed vaccination. We report the case of a Vaccinia infection in a previously vaccinated researcher working with various genetically modified strains. We could confirm the infection by electron microscopy, positive cell culture, virus-specific PCR, sequence analysis, and viral neutralization test. The isolated virus carried a functionally inactivated cytohesin-1 gene of human origin, which had been shown to impair leukocyte adhesion by interacting with the LFA/ICAM-1 axis. The immunomodulating nature of the inserted construct might thus have added to the infectivity of the virus. We emphasize on the necessity of Vaccinia vaccination in laboratory staff working in the field.